VIMPAT 10 mg/ml, syrup bottle, 200 ml
Active ingredients: Lacosamide
Commercialized according to BDPMDispensing in France: Prescription only
Syrupbottle, 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIMPAT 10 mg/mL, sirop
- Pharmaceutical form
- sirop
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 200 ml avec gobelet(s) doseur(s) polypropylène avec seringue(s) pour administration orale polyéthylène polypropylène avec adaptateur polyéthylène
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 May 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65347326CIP72219814CIP133400922198149Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACOSAMIDEsirop | 10 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.